Fig. 1From: HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic studyProportion of participants (n = 10) with plasma viral load < 40 copies/mLBack to article page